← FDA DRUG APPROVALS

FDA ANDA · ANDA079020

ATOMOXETINE HYDROCHLORIDE

Sponsor: SUN PHARMA GLOBAL

APPLICATION
ANDA079020
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
None (Tentative Approval)

Products

ATOMOXETINE HYDROCHLORIDENone (Tentative Approval)
ATOMOXETINE HYDROCHLORIDE 10MG · CAPSULE · ORAL
ATOMOXETINE HYDROCHLORIDENone (Tentative Approval)
ATOMOXETINE HYDROCHLORIDE 80MG · CAPSULE · ORAL
ATOMOXETINE HYDROCHLORIDENone (Tentative Approval)
ATOMOXETINE HYDROCHLORIDE 40MG · CAPSULE · ORAL
ATOMOXETINE HYDROCHLORIDENone (Tentative Approval)
ATOMOXETINE HYDROCHLORIDE 18MG · CAPSULE · ORAL
ATOMOXETINE HYDROCHLORIDENone (Tentative Approval)
ATOMOXETINE HYDROCHLORIDE 100MG · CAPSULE · ORAL
ATOMOXETINE HYDROCHLORIDENone (Tentative Approval)
ATOMOXETINE HYDROCHLORIDE 60MG · CAPSULE · ORAL
ATOMOXETINE HYDROCHLORIDENone (Tentative Approval)
ATOMOXETINE HYDROCHLORIDE 25MG · CAPSULE · ORAL

Approval history

2012-05-11OriginalTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →